Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of (1S,2S,3E,7E,11E)-3,7,11,15-Cembratetraen-17,2-Olide (LS-1) from Lobophyyum sp. on the Apoptosis Induction of SNU-C5 Human Colorectal Cancer Cells

  • Received : 2016.02.01
  • Accepted : 2016.05.12
  • Published : 2016.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

(1S,2S,3E,7E,11E)-3,7,11,15-cembratetraen-17,2-olide (LS-1), a marine cembrenolide diterpene, has anticancer activity against colon cancer cells such as HT-29, SNU-C5/5-FU (fluorouracil-resistant SNU-C5) and SNU-C5. However, the action mechanism of LS-1 on SNU-C5 human colon cancer cells has not been fully elucidated. In this study, we investigated whether the anticancer effect of LS-1could result from apoptosis via the modulation of $Wnt/{\beta}$-catenin and the TGF-${\beta}$ pathways. When treated with the LS-1, we could observe the apoptotic characteristics such as apoptotic bodies and the increase of sub-G1 hypodiploid cell population, increase of Bax level, decrease of Bcl-2 expression, cleavage of procaspase-3 and cleavage of poly (ADP-ribose) polymerase in SNU-C5 cells. Furthermore, the apoptosis induction of SNU-C5 cells upon LS-1 treatment was also accompanied by the down-regulation of $Wnt/{\beta}$-catenin signaling pathway via the decrease of GSK-$3{\beta}$ phosphorylation followed by the decrease of ${\beta}$-catenin level. In addition, the LS-1 induced the activation of TGF-${\beta}$ signaling pathway with the decrease of carcinoembryonic antigen which leads to decrease of c-Myc, an oncoprotein. These data suggest that the LS-1 could induce the apoptosis via the down-regulation of $Wnt/{\beta}$-catenin pathway and the activation of TGF-${\beta}$ pathway in SNU-C5 human colon cancer cells. The results support that the LS-1 might have potential for the treatment of human colon cancer.

Keywords

References

  1. Akiyama, T. (2000) $Wnt/{\beta}$-catenin signaling. Cytokine Growth Factor Rev. 11, 273-282. https://doi.org/10.1016/S1359-6101(00)00011-3
  2. Amado, N. G., Predes, D., Moreno, M. M., Carvalho, I. O., Mendes, F. A. and Abreu, J. G. (2014) Flavonoids and $Wnt/{\beta}$-catenin signaling: potential role in colorectal cancer therapies. Int. J. Mol. Sci. 15, 12094-12106. https://doi.org/10.3390/ijms150712094
  3. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. https://doi.org/10.1016/0003-2697(76)90527-3
  4. Camacho-Leal, P. and Stanners, C. P. (2008) The human carcinoembryonic antigen (CEA) GPI anchor mediates anoikis inhibition by inactivation of the intrinsic death pathway. Oncogene 27, 1545-1553. https://doi.org/10.1038/sj.onc.1210789
  5. Chiarugi, V., Magnelli, L., Cinelli, M. and Basi, G. (1994) Apoptosis and the cell cycle. Cell. Mol. Biol. Res. 40, 603-612.
  6. Constantinou, C., Papas, A. and Constantinou, A. I. (2008) Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs. Int. J. Cancer 123, 739-752. https://doi.org/10.1002/ijc.23689
  7. Fried, J., Perez, A. G. and Clarkson, B. D. (1976) Flow cytofluorometric analysis of cell cycle distributions using propidium iodide. Properties of the method and mathematical analysis of the data. J. Cell Biol. 71, 172-181. https://doi.org/10.1083/jcb.71.1.172
  8. Han, S. U., Kwak, T. H., Her, K. H., Cho, Y. H., Choi, C., Lee, H. J., Hong, S., Park, Y. S., Kim, Y. S., Kim, T. A. and Kim, S. J. (2008) CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling. Oncogene 27, 675-683. https://doi.org/10.1038/sj.onc.1210686
  9. Hong, J. Y., Boo, H. J., Kang, J. I., Kim, M. K., Yoo, E. S., Hyun, J. W., Koh, Y. S., Kim, G. Y., Maeng, Y. H., Hyun, C. L., Chang, W. Y., Kim, Y. H., Kim, Y. R. and Kang, H. K. (2012) (1S,2S,3E,7E,11E)-3,7,11,15-Cembratetraen-17,2-olide, a cembrenolide diterpene from soft coral Lobophytum sp., inhibits growth and induces apoptosis in human colon cancer cells through reactive oxygen species generation. Biol. Pharm. Bull. 35, 1054-1063. https://doi.org/10.1248/bpb.b11-00024
  10. Hoosein, N. M., McKnight, M. K., Levine, A. E., Mulder, K. M., Childress, K. E., Brattain, D. E. and Brattain, M. G. (1989) Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp. Cell Res. 181, 442-453. https://doi.org/10.1016/0014-4827(89)90101-8
  11. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. and Thun, M. J. (2008) Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96. https://doi.org/10.3322/CA.2007.0010
  12. Kim, E. J., Kang, J. I., Kwak, J. W., Jeon, C. H., Tung, N. H., Kim, Y. H., Choi, C. H., Hyun, J. W., Koh, Y. S., Yoo, E. S. and Kang, H. K. (2015) The anticancer effect of (1S,2S,3E,7E,11E)-3,7,11, 15-cembratetraen-17,2-olide(LS-1) through the activation of $TGF-{\beta}$ signaling in SNU-C5/5-FU, fluorouracil-resistant human colon cancer cells. Mar. Drugs 13, 1340-1359. https://doi.org/10.3390/md13031340
  13. Li, Y., Cao, H., Jiao, Z., Pakala, S. B., Sirigiri, D. N., Li, W., Kumar, R. and Mishra, L. (2010) Carcinoembryonic antigen interacts with TGF-{beta} receptor and inhibits TGF-{beta} signaling in colorectal cancers. Cancer Res. 70, 8159-8168. https://doi.org/10.1158/0008-5472.CAN-10-1073
  14. Nguyen, H. T., Chau, V. M., Phan, V. K., Hoang, T. H., Nguyen, H. N., Nguyen, X. C., Tran, H. Q., Nguyen, X. N., Hyun, J. H., Kang, H. K. and Kim, Y. H. (2010) Chemical components from the Vietnamese soft coral Lobophytum sp. Arch. Pharm. Res. 33, 503-508. https://doi.org/10.1007/s12272-010-0402-3
  15. Nicklas, D. and Saiz, L. (2013) Characterization of Negative Feedback Network Motifs in the $TGF-{\beta}$ Signaling Pathway. PLoS ONE 8, e83531. https://doi.org/10.1371/journal.pone.0083531
  16. Pendas-Franco, N., Aguilera, O., Pereira, F., Gonzalez-Sancho, J. M. and Munoz, A. (2008) Vitamin D and $Wnt/{\beta}$-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res. 28, 2613-2623.
  17. Portella, G., Cumming, S. A., Liddell, J., Cui, W., Ireland, H., Akhurst, R. J. and Balmain, A. (1998) Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ. 9, 393-404.
  18. Romano, S., Mallardo, M., Chiurazzi, F., Bisogni, R., D'Angelillo, A., Liuzzi, R., Compare, G. and Romano, M. F. (2008) The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells. Haematologica. 93, 1039-1048. https://doi.org/10.3324/haematol.12402
  19. Samara, R. N., Laguinge, L. M. and Jessup, J. M. (2007) Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling. Cancer Res. 67, 4774-4782. https://doi.org/10.1158/0008-5472.CAN-06-4315
  20. Schneikert, J. and Behrens, J. (2007) The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut. 56, 417-425. https://doi.org/10.1136/gut.2006.093310
  21. Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D. and Boyd, M. R. (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827-4833.
  22. Sheen, Y. Y., Kim, M. J., Park, S. A., Park, S. Y. and Nam, J. S. (2013) Targeting the transforming growth factor-$\beta$ signaling in cancer therapy. Biomol. Ther. (Seoul) 21, 323-331. https://doi.org/10.4062/biomolther.2013.072
  23. Song, L., Li, Z. Y., Liu, W. P. and Zhao, M. R. (2015) Crosstalk between $Wnt/{\beta}$-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy. Cancer Biol. Ther. 16, 1-7. https://doi.org/10.4161/15384047.2014.972215
  24. Sun, L., Wu, G., Willson, J. K., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X. F. and Brattain, M. G. (1994) Expression of transforming growth factor $\beta$ type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem. 269, 26449-26455.
  25. Thuault, S., Valcourt, U., Petersen, M., Manfioletti, G., Heldin, C. H. and Moustakas, A. (2006) Transforming growth factor-$\beta$ employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 174, 175-183. https://doi.org/10.1083/jcb.200512110
  26. Xu, Y. and Pasche, B. (2007) $TGF-{\beta}$ signaling alterations and susceptibility to colorectal cancer. Hum. Mol. Genet. 16 Spec No 1, R14-R20. https://doi.org/10.1093/hmg/ddl486

Cited by

  1. Ginkgo biloba L. leaf extract offers multiple mechanisms in bridling N -methylnitrosourea – mediated experimental colorectal cancer vol.95, 2017, https://doi.org/10.1016/j.biopha.2017.08.103
  2. Reactive oxygen species-mediated phosphorylation of p38 signaling is critically involved in apoptotic effect of Tanshinone I in colon cancer cells vol.32, pp.10, 2018, https://doi.org/10.1002/ptr.6126
  3. Gomisin G Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing AKT Phosphorylation and Decreasing Cyclin D1 vol.26, pp.3, 2018, https://doi.org/10.4062/biomolther.2017.235